MarketInOut Stock Screener Log In | Sign Up
 

AbbVie Inc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 06/18/2026
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization393,058 mln
Float1,764 mln
Earnings Date07/24/2026

EPS

2.05
Stretched

P / E

106
Highly speculative

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.68
Likely reliable

1-Year Forecast

254
Attractive

Relative Strength

19 / 100
Significantly lagging

Business Description

AbbVie is a global pharmaceutical company founded in 2012 and based in North Chicago, Illinois, that develops and sells treatments across a wide range of medical conditions. Its portfolio includes medicines for blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, and eye conditions, as well as therapies for hepatitis C and digestive health. The company also has a strong presence in aesthetics, offering products such as Botox and the Juvederm collection for cosmetic and skin-related treatments.

Key Fundamentals

EPS2.05
P/E106
RPS35.43
ROIC11.24
ROA2.68
Interest Cover7.16
EBITDA, mln16,921
EV / EBITDA26.06
EV / EBIT49.62
Revenue, mln62,819
EV / Revenue7.02

Financial Strength

Altman Z-Score2
Piotroski F-Score 5 / 9
Beneish M-Score-2.68
Price to Intrinsic Value2.18
1-Year Target Price254
Shiller PE Ratio47.43
Short Ratio3.88
Short % of Float1.46

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.68% 14 / 100   
1 Month 1.28% 44 / 100   
2 Months -3.15% 21 / 100   
6 Months -1.66% 23 / 100   
1 Year 20.47% 57 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us